^
    Back
    Association details:
    Biomarker:ALK rearrangement
    Cancer:Renal Cell Carcinoma
    Drug:Xalkori (crizotinib) (ALK inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C4 – Case Studies
    Source:
    Transl Androl Urol
    Title:

    Anaplastic lymphoma kinase (ALK) rearrangement in adult renal cell carcinoma with lung metastasis: a case report and literature review

    Published date:
    12/01/2020
    Excerpt:
    We report a female patient born in 1984...postoperative pathological findings confirmed the morphology of papillary RCC...FISH where results showed ALK rearrangement...The patient is still under treatment with crizotinib, and a stable disease state was revealed by a CT scan in December 2019.
    DOI:
    10.21037/tau-20-1343